Stocks · HKEX · Healthcare · Hong Kong
2269.HK — WuXi Biologics
WuXi Biologics (2269.HK) is a healthcare stock listed on HKEX (Hong Kong). At the close of September 29, 2026 it traded at 53.50 (+0.19% on the day), +8.1% over one month, +42.4% over three months, +41.6% over twelve months. The InvestMuse composite score is +31 on a −100 to +100 scale, a bullish read that ranks #258 of about 1,221 assets. The strongest of its nine dimensions are Momentum (+100) and Trend (+68); the weakest is Regime (hidden Markov model) (-30). Its volatility regime from the hidden Markov model is Cool.
The facts
| Last close | 53.50 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | +0.19% / +8.1% / +42.4% / +41.6% |
| 52-week range | 29.70 – 53.50 |
| Composite score | +31 / 100 · bullish view · rank #258 |
| Volatility regime (HMM) | Cool |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)-30
- Technical indicators-24
- Trend+68
- Support / resistance0
- Fundamentals0
- Sector edge0
- News sentiment0
- Momentum+100
- Chart patterns and zones+55
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.